Helix BioPharma Market Cap

Helix BioPharma has a market cap or net worth of $52.77 million as of July 3, 2025. Its market cap has increased by 53.06% in one year.

Market Cap

52.77M

Enterprise Value

52.24M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.60

Market Cap Chart

Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 52.77M, an increase of 665.22%. That is a compound annual growth rate of 7.04%.

Market Cap History

Date	Market Cap	% Change
Jul 2, 2025	52.77M	74.03%
Dec 31, 2024	30.32M	-11.99%
Dec 29, 2023	34.45M	8.43%
Dec 30, 2022	31.77M	-5.92%
Dec 31, 2021	33.77M	-36.31%
Dec 31, 2020	53.03M	-58.92%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Veradigm	781.22M
Elite Pharmaceuticals	759.65M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
American Oncology Network	449.82M
Glass House Brands	442.61M
Northwest Biotherapeutics	349.23M

Market Cap Rankings